Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1958 1
1960 1
1963 1
1965 1
1966 1
1969 1
1970 1
1972 1
1973 1
1975 2
1976 1
1977 2
1978 1
1980 2
1986 4
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1995 1
2001 3
2002 1
2003 2
2004 1
2005 3
2006 1
2007 5
2008 2
2009 1
2012 3
2013 3
2014 2
2015 4
2016 2
2017 1
2018 1
2020 4
2021 9
2022 8
2023 9
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Turner NC, Swift C, Jenkins B, Kilburn L, Coakley M, Beaney M, Fox L, Goddard K, Garcia-Murillas I, Proszek P, Hall P, Harper-Wynne C, Hickish T, Kernaghan S, Macpherson IR, Okines AFC, Palmieri C, Perry S, Randle K, Snowdon C, Stobart H, Wardley AM, Wheatley D, Waters S, Winter MC, Hubank M, Allen SD, Bliss JM; c-TRAK TN investigators. Turner NC, et al. Ann Oncol. 2023 Feb;34(2):200-211. doi: 10.1016/j.annonc.2022.11.005. Epub 2022 Nov 22. Ann Oncol. 2023. PMID: 36423745 Free article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Do Not Give Up.
Roux RL, Hall MR, Rustin GJS, Zweifel M. Roux RL, et al. Int J Gynecol Cancer. 2017 Jul;27(6):1060-1062. doi: 10.1097/IGC.0000000000000584. Int J Gynecol Cancer. 2017. PMID: 26575275 Free PMC article. No abstract available.
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.
Vynckier P, Annemans L, Raes S, Amrouch C, Lindgren P, Májek O, Beyer K, Leenen RCA, Venderbos LDF, Denijs F, van Harten MJ, Helleman J, Chloupková R, Briers E, Vasilyeva V, Rivas JG, Basu P, Chandran A, van den Bergh RCN, Collen S, Van Poppel H, Roobol MJ; Members of the PRAISE-U Consortium. Vynckier P, et al. Eur Urol. 2024 Nov;86(5):400-408. doi: 10.1016/j.eururo.2024.04.036. Epub 2024 May 23. Eur Urol. 2024. PMID: 38789306 Free PMC article. Review.
Performance of parotidectomy in nonspecialist centers.
Umapathy N, Holmes R, Basavaraj S, Roux R, Cable HR. Umapathy N, et al. Among authors: roux r. Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):925-8; discussion 928. doi: 10.1001/archotol.129.9.925. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12975262 Review.
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Nicum S, McGregor N, Austin R, Collins L, Dutton S, McNeish I, Glasspool R, Hall M, Roux R, Michael A, Clamp A, Jayson G, Kristeleit R, Banerjee S, Mansouri A. Nicum S, et al. Among authors: roux r. Br J Cancer. 2024 Apr;130(6):941-950. doi: 10.1038/s41416-023-02567-6. Epub 2024 Jan 20. Br J Cancer. 2024. PMID: 38245661 Free PMC article. Clinical Trial.
Particle assemblies: toward new tools for regenerative medicine.
Roux R, Ladavière C, Montembault A, Delair T. Roux R, et al. Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):997-1007. doi: 10.1016/j.msec.2012.12.002. Epub 2012 Dec 11. Mater Sci Eng C Mater Biol Appl. 2013. PMID: 23827536 Review.
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.
Beyer K, Leenen R, Venderbos LDF, Helleman J, Denijs F, Bramer W, Vasilyeva V, Briers E, Rivas JG, Chloupkova R, Majek O, Annemans L, Vynckier P, Basu P, Chandran A, van den Bergh R, Collen S, van Poppel H, Roobol MJ; The PRAISE-U Consortium. Beyer K, et al. J Pers Med. 2024 Jan 11;14(1):84. doi: 10.3390/jpm14010084. J Pers Med. 2024. PMID: 38248785 Free PMC article. Review.
98 results